Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261544 · ClinicalTrials.gov registry record
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
A clinical trial of Sarcoma and Bone Metastases, sponsored by Duke University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT03261544: Recruiting study of Sarcoma and Bone Metastases, sponsored by Duke University.
NCT03261544 is a study of Sarcoma and Bone Metastases that is actively recruiting participants, run by Duke University. The registered enrollment target is 50 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03261544, a study of Sarcoma and Bone Metastases, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique. The investigators hypothesize that those patients who receive reattachment of the abductors directly into the prosthesis will have better functional outcomes overall. Furthermore, the investigators plan to develop a simple, cost effective, and reproducible method to assess abductor function at clinical post-operative visits through plain radiographs.
Primary Outcome
The Musculoskeletal Tumor Society (MSTS) score of extremity function. The total score ranges from 0 to 30, with higher scores indicating better function.
Conditions Studied
Interventions
- PROCEDURE Proximal Femur Replacement
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-11-10 |
| Est. Completion | 2028-11 |
What NCT03261544 shows while recruiting
NCT03261544 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Proximal Femur Replacement is the first listed.
NCT03261544 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03261544 about?
NCT03261544 is a clinical study titled "Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?". The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique. The investigators hypothesize that those patients who receive reattachment of the abductors directl...
What is the current status of trial NCT03261544?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-11-10. Estimated completion is 2028-11.
What conditions does trial NCT03261544 study?
This clinical trial studies the following conditions: Sarcoma, Bone Metastases, Proximal Femur Replacement.
What interventions are being tested in trial NCT03261544?
The interventions under investigation include: Proximal Femur Replacement (PROCEDURE).
Who is sponsoring clinical trial NCT03261544?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03261544 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03261544's enrollment target sits among peer trials
50 67th of 122 higher than 55 of 122 other Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
-
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy